Evidence map›Paper›PMID 36701338›Full record

ArticlePloS one2023

Mitigating the outbreak of an infectious disease over its life cycle: A diffusion-based approach.

Xiaoming Li, Conghu Wang, Bin Jiang, Hua Mei

Abstract read
In one paragraph

Article in PloS one, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Xiaoming LiDepartment of Business Administration, Tennessee State University, Nashville, Tennessee, United States of America.ORCID 0000-0001-7085-2768
Conghu WangDepartment of Public Administration, Renmin University of China, Beijing, China.
Bin JiangDepartment of Pharmacy Administration and Clinical Pharmacy, Peking University, Beijing, China.
Hua MeiDepartment of Chemistry & Physics, Belmont University, Nashville, Tennessee, United States of America.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We first qualitatively divide the cycle of an infectious disease outbreak into five distinct stages by following the adoption categorization from the diffusion theory. Next, we apply a standard mechanistic model, the susceptible-infected-recovered model, to simulate a variety of transmission scenarios and to quantify the benefits of various countermeasures. In particular, we apply the specific values of the newly infected to quantitatively divide an outbreak cycle into stages. We therefore reveal diverging patterns of countermeasures in different stages. The stage is critical in determining the evolutionary characteristics of the diffusion process. Our results show that it is necessary to employ appropriate diverse strategies in different stages over the life cycle of an infectious disease outbreak. In the early stages, we need to focus on prevention, early detection, and strict countermeasure (e.g., isolation and lockdown) for controlling an epidemic. It is better safe (i.e., stricter countermeasures) than sorry (i.e., let the virus spread out). There are two reasons why we should implement responsive and strict countermeasures in the early stages. The countermeasures are very effective, and the earlier the more total infected reduction over the whole cycle. The economic and societal burden for implementing countermeasures is relatively small due to limited affected areas, and the earlier the less burden. Both reasons change to the opposite in the late stages. The strategic focuses in the late stages become more delicate and balanced for two reasons: the same countermeasures become much less effective, and the society bears a much heavier burden. Strict countermeasures may become unnecessary, and we need to think about how to live with the infectious disease.

Indexed as

Communicable DiseasesEpidemicsAnimalsDisease OutbreaksLife Cycle Stages

Identifiers

PMID36701338
PMCPMC9879393

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.